Live Breaking News & Updates on Development Program For Aficamten

Stay updated with breaking news from Development program for aficamten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cytokinetics Provides Update on Cardiac Myosin Inhibitor Programs and Plans to Build a Specialty Cardiology Franchise at Virtual Investor & Analyst Day

New Long-Term Data from FOREST-HCM, the Open-Label Extension Study of Aficamten,Show Sustained Improvements in Clinical Efficacy Endpointsand No Treatment Interruptions for Low Ejection Fraction . ....

San Francisco , United States , Theodore Abraham , Roberti Blum , Diane Weiser , Cytokinetics Incorporated Nasdaq , Symphony Health , School Of Cardiovascular Metabolic Health , Division Of Cardiology , Adult Cardiac Echocardiography Laboratory , Development Program For Aficamten , Globenewswire Inc , Cardiovascular Genetics Center , Us Food Drug Administration , Clinical Trials Program , Market Research , Corporate Communications , Journal Of The American College Cardiology , Cytokinetics Incorporated , Exchange Commission , Clinical Research , Research Evaluation Of Sustained Treatment , Harvard Medical School , National Medical Products Administration , New Long Term Data , Open Label Extension Study ,

Cytokinetics Reports Fourth Quarter 2021 Financial Results

Cytokinetics Reports Fourth Quarter 2021 Financial Results
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Ji Xing , United States , Joanna Siegall , Omecamtiv Mecarbil , Roberti Blum , Cytokinetics Incorporated , Skeletal Muscle Program , American Heart Association , Medicinal Chemistry Gordon Research Conference , Ji Xing Pharmaceuticals Limited , Contact Center , Clinical Development , Ongoing Research , American College Of Cardiology , International Symposium , Drug Administration , Development Program For Aficamten , Exchange Commission , Cytokinetics Incorporated Nasdaq , Corporate Communications , National Medical Products Administration , Investigator Sponsored Study Program , Commercial Launch Readiness Activities Underway , Aficamten Expanding , New Drug Application , Cytokinetic President ,